Kashofer, K; Halbwedl, I; Winter, E; Hoefler, G; Asslaber, M
Expanding on WHO guideline compliant molecular testing of central nervous system tumours by low density whole genome sequencing
VIRCHOWS ARCH. 2018; 473: S28-S28.-ECP European Congress of Pathology; SEP 8-12,2018; Bilbao, SPAIN.
[Oral Communication]
Web of Science
Kashofer, K; Thuringer, A; Halbwedl, I; Asslaber, M; Wackernagel, W
Comprehensive diagnosis and monitoring of uveal melanoma with gene panel analysis, low density whole genome sequencing and digital droplet PCR
VIRCHOWS ARCH. 2018; 473: S28-S29.-ECP European Congress of Pathology; SEP 8-12,2018; Bilbao, SPAIN.
[Oral Communication]
Web of Science
Kashofer, K; Jahn, S; Halbwedl, I; Hoetler, G
Beyond BRCA-HRD scoring using Affymetrix Oncoscan microarrays
VIRCHOWS ARCH. 2016; 469: S203-S203.
[Poster]
Web of Science
Anders, I; Asslaber, M; Golob-Schwarzl, N; Halbwedl, I; Gogg-Kamerer, M; Al-Effah, M; Hoffmann, J; Rolff, J; Popper, H; Haybaeck, J
Particular components of the translation machinery drive lung cancer formation
VIRCHOWS ARCH. 2015; 467: S258-S258.
[Poster]
Web of Science
Anders, I; Asslaber, M; Golob-Schwarzl, N; Halbwedl, I; Gogg‑Kamerer, M; Al-Effah, M; Hoffmann, J; Rolff, J; Popper, H; Haybaeck, J
Particular components of the translation machinery drive lung cancer formation
. 2015; -3rd International Student Congress; JUN 3-5, 2015; Graz, AUSTRIA.
[Oral Communication]
Kashofer, K; Winter, E; Halbwedl, I; Thuringer, A; Regauer, S
High incidence of TP53 mutations in HPV-negative penile carcinomas revealed by NGS analysis
VIRCHOWS ARCH. 2015; 467: S22-S22.-27th European Congress of Pathology; SEP 5 - 9, 2015; Belgrade, SERBIA.
[Oral Communication]
Web of Science
Matak, A; Jahn, S; Viertler, C; Thuringer, A; Halbwedl, I; Langner, C; Hoefler, G; Kashofer, K
Genetic heterogeneity of colorectal carcinoma in NGS analysis: A complication for molecular diagnosis?
VIRCHOWS ARCH. 2015; 467: S166-S167.-European Congress of Pathology; SEP 5-9, 2015; Belgrade, SERBIA.
[Poster]
Web of Science
Arzt, L; Quehenberger, F; Halbwedl, I; Popper, HH;
STAT signaling is deregulated in malignant pleural mesothelioma: reasons and consequences.
6th ÖGMBT Annual Meeting - Abstractbook. 2014; -6th ÖGMBT Annual Meeting; SEP 15-18, 2014; Vienna, AUSTRIA.
[Oral Communication]
Petzold,J; Lederer, E; Reihs, R; Ernst, C; Bettermann, K; Halbwedl, I; Lax, S; Park, N Y; Kim, K S; Kiessslich, T; Pichler, M; Haybaeck, J
PTEN Inactivation and Alteration of the PI3K/AKT/mTOR Pathway in Biliary Tract Cancer
Anticancer Research. 2014; 34(10):5942-5942.-9th International Conference of Anticancer Research; OCT 6-10, 2014; Sithonia, Greece.
[Poster]
Web of Science
Arzt, L; Quehenberger, F; Halbwedl, I; Popper, HH
STAT signaling is totally deregulated in malignant pleural mesothelioma: What are the reasons.
CANCER RES. 2013; 73(8):-104th Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 06-10, 2013; Washington, DC.
Doi: 10.1158/1538-7445.AM2013-5267
[Poster]
Web of Science
FullText
FullText_MUG
Arzt, L; Quehenberger, F; Halbwedl, I; Popper, HH;
The impact of microRNAs on the STAT signaling pathway in malignant mesothelioma
Abstract Book of the Keystone Symposia on Noncoding RNAs in Development and Cancer. 2013; -Noncoding RNAs in Development and Cancer; JAN 20-25, 2013; Vancouver, CANADA.
[Poster]
Arzt, L; Quehenberger, F; Halbwedl, I; Popper, HH;
The regulation of the STAT signaling pathway in malignant pleural mesothelioma: An update
Pneumologie. 2013; 67(5):288-288.-PneuoUpdate 2013; JUN 13-15, 2013; Igls bei Innsbruck, AUSTRIA.
[Poster]
Arzt, L; Quehenberger, F; Halbwedl, I; Popper, HH;
STAT signaling is deregulated in malignant pleural mesothelioma: Are microRNAs the reason?
Virchows Archiv. 2013; 463(2):126-126.-25th European Congress of Pathology; AUG 31 - SEP 4, 2013; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
Arzt, L; Quehenberger, F; Halbwedl, I; Popper, H.H;
What is the reason for the deregulation of the STAT signaling pathway in malignant pleural mesothelioma?
FEBS Journal, Supplement 1. 2012; 279(SI):138-138.-22nd IUBMB / 37th FEBS; SEP 4-9, 2012; Sevilla, SPAIN. (ISBN: 1742-464X )
[Poster]
Web of Science
Arzt, L; Quehenberger, F; Halbwedl, I; Popper, HH;
What is the reason for the deregulation of the STAT signaling pathway in malignant pleural mesothelioma?
YSP 2012, Abstract Book. 2012; -Young Scientists Program 2012; SEP 1-4, 2012; Rota, SPAIN.
[Oral Communication]
Quan, P; Lederer, E; Halbwedl, ; Moinfar, F; Denk, H; Zatloukal, K; Haybaeck, J
Endometriales Stromasarkom: Histondeacetylase und PI3K/Akt/mTOR-Signalweg
96. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V. ; MAY 31 - JUN 3, 2012; Berlin, Germany . 2012.
[Oral Communication]
Quan, P; Lederer, E; Halbwedl, I; Denk, H; Zatloukal, K; Haybaeck, J;
Targeting endometrial stromal sarcoma: Histone deacetylase and PI3K/Akt/mTOR signaling.
VIRCHOWS ARCHIV. VIRCHOWS ARCHIV461: S31-S31. NEW YORK: SPRINGER;
[Oral Communication]
Web of Science
Arzt, L; Kothmaier, H; Quehenberger, F; Halbwedl, I; Popper, H.H;
STAT signaling in malignant mesothelioma: Is deregulation of STAT1 and STAT3 caused by microRNAs?.
Proceedings of the 14th World Conference on Lung Cancer, Supplement to Journal of Thoracic Oncology, Supplement 2, Book 1. 2011; 6(6):S709-S709.-14th World Conference on Lung Cancer; JUL 3-7, 2011; Amsterdam, The Netherlands.
[Poster]
Arzt, L; Kothmaier, H; Quehenberger, F; Halbwedl, I; Popper, H.H;
The STAT signaling pathway and its regulation in malignant pleural mesothelioma
Doctoral Day 2011; NOV 4, 2011; Graz, AUSTRIA. 2011.
[Oral Communication]
Arzt, L; Kothmaier, H; Quehenberger, F; Halbwedl, I; Popper, H.H;
The STAT signaling pathway and its regulation in malignant pleural mesothelioma
Doctoral Day 2011; NOV 4, 2011; Graz, AUSTRIA. 2011.
[Poster]
Arzt, L; Kothmaier, H; Quehenberger, F; Halbwedl, I; Popper, HH;
The regulatory effect of microRNAs on STAT signaling in malignant mesothelioma
European Respiratory Journal. 2011; 38: Suppl.55: -ERS European Respiratory Society - Annual Congress; SEP 24-28, 2011; Amsterdam, The Netherlands.
[Oral Communication]
Mairinger, F; Vollbrecht, C; Hatz, M; Stacher, E; Halbwedl, I; Quehenberger, F; Mairinger, T; Popper, HH
Association between TS expression levels and response to Pemetrexed in MPM: Fact or fiction?
Proceedings of the 14th World Conference on Lung Cancer, Supplement to Journal of Thoracic Oncology, Supplement 2, Book 2. 2011; 6(6):S981-S982.-14th World Conference on Lung Cancer; JUL 3-7, 2011; Amsterdam, THE NETHERLANDS.
[Poster]
Web of Science
Vollbrecht, C; Mairinger, F; Trajanoski, S; Halbwedl, I; Maierhofer, T; Michelitsch, G; Filipits, M; Schmid, K; Kollmeier, J; Mairinger, T; Popper, H.H;
Very early detection of small clones harboring EGFR mutations in NSCLC by 2nd generation sequencing
Proceedings of the 14th World Conference on Lung Cancer, Supplement to Journal of Thoracic Oncology, Supplement 2, Book 1. 2011; 6(6):S450-S451.-14th World Conference on Lung Cancer; JUL 3-7, 2011; Amsterdam, The Netherlands.
[Oral Communication]
Arzt, L; Kothmaier, H; Halbwedl, I; Popper HH
Do microRNA regulate STAT signaling in malignant mesothelioma?
www.jak-stat.at2010; -FEBS Meeting.Jak-Stat signaling: From Basics to Disease; FEB 10-13, 2010; Vienna, AUSTRIA.
[Poster]
Arzt, L; Kothmaier, H; Quehenberger, F; Halbwedl, I; Popper, HH
STAT signaling in malignant mesothelioma: Is there a regulatory effect of microRNAs?
Pneumoupdate; JUN 17-19,2010; Igls bei Innsbruck; AUSTRIA. 2010.
[Poster]
Allen, TC; Popper, HH; Kothmaier, H; Halbwedl, I; Morbini, P; Murer, B; Comin, CE; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, PT
Osteopontin (OPN) and HIF-1 expression in diffuse malignant mesothelioma (DMM) with long-term (> 3Year) survival (LS) versus short-term survival (SS)
LAB INVEST. 2008; 88: 335A-335A.
[Poster]
Web of Science
Allen, TC; Popper, HH; Kothmaier, H; Halbwedl, I; Morbini, P; Murer, B; Comin, CE; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, PT
Osteopontin (OPN) and HIF-1 expression in diffuse malignant mesothelioma (DMM) with long-term (> 3Year) survival (LS) versus short-term survival (SS)
MODERN PATHOL. 2008; 21: 335A-335A.
[Poster]
Web of Science
Dacic, S; Poppei, HH; Kothmaier, H; Halbwedt, I; Morbini, P; Murer, B; Comin, CE; Galateau-Salle, F; Demirag, F; Zeren, H; Allanoos, R; Gibbs, A; Cagle, PT
Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas
MODERN PATHOL. 2008; 21: 339A-340A.
[Poster]
Web of Science
Dacic, S; Popper, HH; Kothmaier, H; Halbwedl, I; Morbini, P; Murer, B; Comin, CE; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, PT
Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas
LAB INVEST. 2008; 88: 339A-340A.
[Poster]
Web of Science
Gruber-Moesenbacher, U; Stacher, E; Morresi-Hauf, A; Papotti, M; Dei Tos, A; Carvalho, L; Huber, M; Halbwedl, I; Gogg-Kamerer, M; Grygar, E; Cavazza, A; Popper, HH
Vascular tumors of the lung and horizons for target therapy
3rd Intercontinental Congress of Pathology; MAY 17-21,2008; Barcelona, SPAIN. 2008.
[Oral Communication]
Kothmaier, H; Becker, KF, Schott, C; Halbwedl, I;Popper HH
Measuring STAT1 activation in malignant pleural mesothelioma in FFPE tissue using protein lysate microarrays
Annual meeting of the ANGT, ÖGBT, ÖGGGT, ÖGBM.2008; 61-61.-Life Sciences Graz 2008; SEP 22-24, 2008; Graz, AUSTRIA.
[Poster]
Kothmaier, H; Rohrer, D; Halbwedl, I; Popper, HH
Comparison of three commercially, non-crosslinking fixatives: A proteomic study testing their application for routine and research.
HISTOPATHOLOGY. Histopathology Suppl.12008; 53: 685-299.-27th International Congress of the International-Academy-of-Pathology; OCT 12-17, 2008; Athens, GREECE.
[Poster]
Web of Science
Popper, HH; Hallbwedl, I; Kothmaier, H
Experimental Target Therapy in Mesothelioma Cells.
European Respiratory Journal
Supplement2008; 32(52):628-628.-Annual Congress of the European Respiratory Society; OCT 4-8, 2008; Berlin, GERMANY.
[Poster]
Stacher, E; Gruber-Moesenbacher, U; Papotti, M; Tos, APD; Carvalho, L; Huber, M; Halbwedl, I; Gogg-Kamerer, M; Grygar, E; Cavazza, A; Popper, HH
The VEGF-signalling pathway in vascular and perivascular tumors of the lung
VIRCHOWS ARCHIV. 2008; 452: S55-S56.-3rd Intercontinental Congress of Pathology; MAY 17-21,2008; Barcelona, SPAIN.
[Poster]
Web of Science
Stacher, E; Leibl, S; Ullmann, R; Halbwedl, I; Boldt, V; Popper, H; Moinfar, F
Chromosomal aberrations in coexisting lobular and ductal intraepithelial neoplasia (low grade) of the breast, an array CGH study
HISTOPATHOLOGY. 2008; 53: 147--27th International Congress of the International-Academy-of-Pathology; OCT 12-17, 2008; Athens, GREECE.
[Poster]
Web of Science
Kothmaier, H; Quehenberger, F; Halbwedl, I; Popper, HH
Translation of tissue-microarray data into RNA-interference and gene expression approaches identifies promising targests in malignant pleural mesothelioma.
Scientific Lung Day Graz; April 28, 2007; Graz, Austria. 2007.
[Poster]
Kothmaier H; Quehenberger, F; Halbwedl, I; Popper, HH
Proliferation, antiapoptosis and angiogenesis pathways differently regulated in epitheloid mesotheliomas from short- and long-term survivors.
Proceedings of the 100th Annual Meeting of the American Association for Cancer Research (AACR); Abstract nr {4490} 2007; -AACR Annual Meeting; Apr 14-18, 2007; Los Angeles, USA.
[Poster]
Kothmaier, HE; Quehenberger, F; Halbwedl, I; Popper, HH
Favored signaling pathways in short- and long-term survivors of pleural mesothelioma.
FASEB J. 2007; 21(5):A383-A383.-Experimental Biology Meeting; APR 28-2 MAI, 2007; Washington DC, USA.
[Oral Communication]
Web of Science
Stacher, E; Quehenberger, F; Halbwedl, I; Gogg-Kamerer, M; Grygar, E; Popper, HH
The VEGF-signalling Pathway in Pulmonary Small and NON-Small Cell Carcinomas - An Immunohistochmical Comparative Study.
Virchows Archiv2007; 451(2):179--21st European Congress of Pathology; SEP 8-13, 2007; Istanbul, TURKEY. (ISBN: 0945-6317 )
[Oral Communication]
Web of Science
Stacher, E; Quehenberger, F; Markert, E; Halbwedl, I; Gogg-Kamerer, M; Grygar, E; Cagle, PT; Popper, HH
Differences in growth signaling pathway activation in pulmonary small and non-small cell carcinomas - An immunohistochemical study
LAB INVEST. 87: 332A-332A.-Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology; ; MARCH 24-30, 2007; San Diego, USA.
[Poster]
Web of Science
Stacher, E; Quehenberger, F; Markert, E; Halbwedl, I; Gogg-Kamerer, M; Grygar, E; Cagle, PT; Popper, HH
Differences in growth signaling pathway activation in pulmonary small and non-small cell carcinomas - An immunohistochemical study
MODERN PATHOL. 20: 332A-332A.-Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology; MARCH 24-30, 2007; San Diego, USA.
[Poster]
Web of Science
Stacher, E; Quehenberger, F; Markert, E; Halbwedl, I; Gogg-Kamerer, M; Grygar, E; Popper, HH
The VEGF-signalling pathway in Pulmonary Small and Non-Small Cell Carcinomas - An Immunohistochemical Comparative Study.
Scientific Lung Day Graz; APRIL 28, 2007; Graz, AUSTRIA. 2007.
[Poster]
Halbwedl, I; Quehenberger, F; Stacher, E; Markert, E; Gogg-Kamerer, M; Grygar, E; Popper, HH
Immunohistochemistry-Based Tissue Microarray Analysis of Lung Adenocarcinomas
Arch Pathol Lab Med. 130: 1393-1394.-The College of American Pathologists 2006 Annual Meeting (CAP `06); SEP 10-13, 2006; San Diego, USA.
[Poster]
Kothmaier, H; Petzmann, S; Halbwedl, I; Popper, HH
RNAi of PCNA in Mesothelioma Cells Causes Deregulation in Cell Cycle Interactions.
Cytotherapy. -4th Annual Meeting of the European Tissue Engineering Society; Aug. 31 - Sep. 3, 2005; Munich, GERMANY.
[Poster]
Markert, E; Quehenberger, F; Stacher, E; Halbwedl, I; Gogg-Kamerer, M; Grygar, E; Popper, HH
Pathway Analysis in Squamous Cell Lung Cancer
Arch Pathol Lab Med. 130: 1392-1393.-The College Of American Pathologists 2006 Annual Meeting (CAP `06); SEP 10-13, 2006; San Diego, USA.
[Poster]
Popper, HH; Halbwedl, I; Morbini, P; Cagle, PT; Murer, B; Comin, CE; Galateau-Salle, F; Zeren, H; Funda, S; Attanoos, R; Gibbs, A
Long and short time survivors of malignant epitheloid mesothelioma: A genetic and immunohistochemical study
LAB INVEST. 86: 315A-315A.-95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology; FEB 11-17, 2006; Atlanta, GA.
[Oral Communication]
Web of Science
Popper, HH; Halbwedl, I; Morobini, P; Cagle, PT; Murer, B; Comin, CE; Galateau-Salle, F; Zeren, H; Funda, S; Attanoos, R; Gibbs, A
Long and short time survivors of malignant epitheloid mesothelioma: A genetic and immunohistochemical study
MODERN PATHOL. 19: 315A-315A.-95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology; FEB 11-17, 2006; Atlanta, GA.
[Oral Communication]
Web of Science
Popper, HH; Kothmaier, H; Halbwedl, I; Morbini, P; Cagle, PT; Murer, B; Comin, C; Galateau-Salle, F; Zeren, H; Attanoos, R; Gibbs, A
Different growth regulation in malignant mesotheliomas in long and short time survivors.
European Respiratory Society Annual Congress 2006; SEP 2-6, 2006; Munich, GERMANY. 2006.
[Oral Communication]
Popper, HH; Kothmaier, H; Stacher, E; Markert, E; Quehenberger, F; Halbwedl, I; Gogg-Kamerer, M; Cagle, PT
Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung.
All-Russian Pulmonology Congress; NOV 14-16, 2006; St. Petersburg, RUSSIA. 2006.
[Keynote lecture]
Popper, HH; Markert, E; Stacher, E; Quehenberger, F; Halbwedl, I; Gogg-Kamerer, M; Cagle PT
Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung.
European Respiratory Society Annual Congress 2006; SEP 2-6, 2006; Munich, GERMANY. 2006.
[Oral Communication]
Popper, HH; Quehenberger, F; Halbwedl, I; Gogg-Kamerer, M; Grygar, E; Cagle, P
Differences in Growth Signaling Pathway Activation in Small Cell Carcinoma and Large Cell Neuroendocrine Carcinomas of the Lung.
Archives of Pathology and Laboratory Medicine. 130: 1393-1393.-College of American Pathologists´Annual Meeting (CAP ´06); SEP 10-13, 2006; San Diego, USA.
[Poster]
Stacher, E; Quehenberger, F; Markert, E; Halbwedl, I; Gogg-Kamerer, M; Grygar, E; Popper, HH
Growth Signaling Pathway Activation in Pulmonary Large Cell Carcinomas and Pleomorphic Carcinomas
Arch Pathol Lab Med. 130: 1394-1395.-College Of American Pathologists 2006 Annual Meeting (CAP `06); SEP 10-13, 2006; San Diego, USA.
[Poster]
Kothmaier, H; Petzmann, S; Halbwedl, I; Popper, HH
Gene silencing of PCNA in mesothelioma cell lines causes deregulation of other genes
LAB INVEST. 2005; 85: 313A-313A.-94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology; FEB 26-MAR 04, 2005; San Antonio, USA.
Web of Science
Kothmaier, H; Petzmann, S; Halbwedl, I; Popper, HH
Gene silencing of PCNA in mesothelioma cell lines causes deregulation of other genes
MODERN PATHOL. 2005; 18: 313A-313A.-94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology; FEB 26-MAR 04, 2005; San Antonio, USA.
Web of Science
Popper, HH; Ullmann, R; Halbwedl, I; Petzmann, S
Complex chromosomal aberrations in pulmonary adenocarcinomas detected by array-CGH
MODERN PATHOL 2005 18: 316A-317A.
Web of Science
Popper, HH; Ullmann, R; Halbwedl, I; Petzmann, S
Complex chromosomal aberrations in pulmonary adenocarcinomas detected by array-CGH
LAB INVEST 2005 85: 316A-317A.
Web of Science
Ullmann, R; Petzmann, S; Bongiovanni, M; Halbwedl, I; Gogg-Kammerer, M; Papotti, M; Fraire, AE; Cagle, PT; Mori, M; Popper, HH
Bronchiolar columnar cell dysplasia - Genetic analysis of a novel preneoplasia of the peripheral lung
MODERN PATHOL 2002 15: 1373-1373.
Web of Science
Ullmann, R; Petzmann, S; Bongiovanni, M; Halbwedl, I; Gogg-Kammerer, M; Papotti, M; Fraire, AE; Cagle, PT; Mori, M; Popper, HH
Bronchiolar columnar cell dysplasia - Genetic analysis of a novel preneoplasia of the peripheral lung
LAB INVEST 2002 82: 1373-1373.
Web of Science